Singapore markets closed

Straits Times Index
3,316.56
-6.06(-0.18%)
Nikkei
38,646.11
-457.11(-1.17%)
Hang Seng
18,608.94
-259.77(-1.38%)
FTSE 100
8,317.59
-21.64(-0.26%)
Bitcoin USD
69,263.16
+731.69(+1.07%)
CMC Crypto 200
1,451.27
-16.84(-1.15%)

PFE Jan 2026 32.500 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

2.5100

0.0000

(0.00%)

At close: 02:04PM EDT

Zacks
Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
AstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer (PFE) announces a multi-year, multi-phase cost reduction program.
Zacks
Pfizer (PFE) Starts Another Cost-Cut Plan to Save $1.5B by 2027
This is the second cost-reduction program undertaken by Pfizer (PFE) in the past year. The first phase of this program is expected to save nearly $1.5 billion by 2027-end.
Zacks
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
The Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE) to develop bird flu vaccines over increasing fears of widespread transmission of the infection.